Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This concurrent, two-part study will:
I) Using overnight sleep recordings, evaluate the short- and long-term sleep-promoting
effects of the antidepressant mirtazapine (Remeron) in patients who have been prescribed this
medication for major depressive disorder and sleep disruption.
II) Investigate the psychomotor performance of depressed patients using driving simulation
testing before and during treatment with mitrazapine.